The effectiveness of lutein in high myopic patients
Not Applicable
- Conditions
- high myopia
- Registration Number
- JPRN-UMIN000025635
- Lead Sponsor
- Department of Ophthalmology, Tokyo Medical and Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who have serious retinal diseases such as glaucoma, age related macular degeneration and bleeding. Patients who have severe kidney disease , heart failure and hepatitis. People who have taken administration of lutein in 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The study of contrast sensitivity at baseline, 3-month and 6-month from baseline.
- Secondary Outcome Measures
Name Time Method The study of visual acuity, concentration of macular pigmentation and ERG at baseline, 3-month and 6-month from baseline.